LivaNova PLC chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 19.03
Dividend & YieldN/A$ (N/A)
Beta 0.85
Market capitalization 2.83B
Operating cash flow 84.7M
ESG Scores unknown

Company description

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio0.82
Working Capital7.63
Return On Equity-0.1
Debt To Equity0.01
Fixed Asset Ratio0.27
Fixed Interest Cover1.02

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 11.03M -38.58M -923k 12.99M
Total Cashflows From Investing Activities -120.56M -41.29M -41.84M 36.9M
Net Borrowings 29M 172.95M 407.05M -452.26M
Total Cash From Financing Activities -42.35M 146.58M 310.76M -181.48M
Change To Operating Activities 284.74M -125.77M -173.92M 27.39M
Issuance Of Stock 322.56M 322.56M 322.56M 322.56M
Net Income -189.4M -157.64M -348.82M -135.82M
Change In Cash -46.41M 13.93M 191.69M -44.84M
Effect Of Exchange Rate -4M -216k 2.21M -2.81M
Total Cash From Operating Activities 120.49M -91.14M -79.42M 102.54M
Depreciation 69.94M 82.99M 81.32M 67.99M
Change To Account Receivables 21.18M -5.32M 58.8M -15.74M
Other Cashflows From Financing Activities -9.73M -19.3M -90.69M -38.84M
Change To Netincome -69.23M 167.34M 285.38M 124.5M
Capital Expenditures -37.19M -24.69M -35.02M -25.48M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 145.95M 146.85M 160.4M 174.31M
Income Before Tax -248.09M -188.38M -348.29M -124.62M
Net Income -189.4M -157.64M -348.82M -135.82M
Selling General Administrative 464.97M 528.47M 446.56M 467.6M
Gross Profit 742.96M 723.8M 581.76M 697.49M
Ebit 94.85M 48.49M -67.4M 51.28M
Operating Income 94.85M 48.49M -67.4M 51.28M
Interest Expense -9.82M -15.09M -43.32M -50.15M
Income Tax Expense -69.63M -30.37M -960k 11.2M
Total Revenue 1.11B 1.08B 934.24M 1.04B
Cost Of Revenue 364M 360.37M 352.48M 337.87M
Total Other Income ExpenseNet -342.94M -236.87M -280.89M -175.9M
Net Income From Continuing Ops -178.46M -158M -347.33M -135.82M
Net Income Applicable To Common Shares -189.4M -157.64M -348.82M -135.82M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 1.05B 1.03B 1.29B 906.31M
Total Stockholder Equity 1.5B 1.38B 1.11B 1.29B
Other Current Liabilities 267.48M 226.15M 125.03M 272.27M
Total Assets 2.55B 2.41B 2.4B 2.2B
Common Stock 76.14M 76.26M 76.3M 82.3M
Other Current Assets 236k 72.59M 106.63M
Retained Earnings -251.58M -406.75M -761.97M -897.78M
Treasury Stock -25.94M -20.66M 26.77M -7.83M
Cash 47.2M 61.14M 252.83M 207.99M
Total Current Liabilities 496.75M 512.55M 309.05M 696.97M
Other Stockholder Equity -24.48M -19.39M 27.81M -7.18M
Property, Plant, and Equipment 191.4M 235.73M 214.33M 190.67M
Total Current Assets 533.3M 549.44M 708.04M 679.18M
Net Tangible Assets -223.52M -139.62M -250.69M -4.56M
Net Receivables 256.74M 258.37M 186.86M 187.85M
Accounts Payable 76.73M 85.89M 73.67M 68M


Insider Transactions

Here are the insider transactions of stock shares related to LivaNova PLC:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SKEFFINGTON KEYNA PIDCOCKD2022-09-15General Counsel300
HEBBELINCK TRUID2022-09-15Officer440
ROSENTHAL ARTHUR LEED2022-06-15Director1.35k
NOVAK ALFRED JD2022-06-15Director1.35k
KOZY WILLIAM AD2022-06-15Director2.26k
SCHERMERHORN TODD CD2022-06-15Director1.35k
ENXING SENG STACYD2022-06-15Director1.35k
MOORE DANIEL JEFFREYD2022-06-15Director1.35k
SAIA ANDREA LYNND2022-06-15Director1.35k
BIANCHI FRANCESCOD2022-06-15Director1.35k
O'KANE SHAROND2022-06-15Director1.35k
SHVARTSBURG ALEXD2022-06-15Chief Financial Officer1.58k
MOORE DANIEL JEFFREYSale at price 83.42 per share.D2022-04-01Director1k
MCDONALD DAMIEND2022-03-30Chief Executive Officer16.94k
SKEFFINGTON KEYNA PIDCOCKD2022-03-30General Counsel2.87k
HEBBELINCK TRUID2022-03-30Officer2.25k
DOLCI MARCOD2022-03-30Officer2.8k
SHVARTSBURG ALEXD2022-03-30Chief Financial Officer1.95k
MCDONALD DAMIENSale at price 81.50 per share.D2022-03-29Chief Executive Officer2.78k
MCDONALD DAMIEND2022-03-15Chief Executive Officer3.18k
SKEFFINGTON KEYNA PIDCOCKD2022-03-15General Counsel459
DOLCI MARCOD2022-03-15Officer558
SHVARTSBURG ALEXD2022-03-15Chief Financial Officer390
MOORE DANIEL JEFFREYSale at price 80.00 per share.D2022-03-02Director1k
MCDONALD DAMIEND2022-03-01Chief Executive Officer5.17k
SKEFFINGTON KEYNA PIDCOCKD2022-03-01General Counsel774
HEBBELINCK TRUID2022-03-01Officer559
DOLCI MARCOD2022-03-01Officer688
MOORE DANIEL JEFFREYSale at price 80.00 per share.D2022-02-25Director1k
MOORE DANIEL JEFFREYSale at price 85.93 per share.D2022-01-03Director1k
SCHERMERHORN TODD CD2021-12-15Director1.02k
SHVARTSBURG ALEXD2021-12-15Chief Financial Officer1.28k
MCDONALD DAMIENSale at price 81.50 per share.D2021-12-13Chief Executive Officer2.78k
MOORE DANIEL JEFFREYSale at price 81.73 per share.D2021-12-01Director1k
NOVAK ALFRED JSale at price 89.17 - 90.77 per share.D2021-11-11Director2.98k
KOZY WILLIAM APurchase at price 90.43 per share.D2021-11-10Director1k
MOORE DANIEL JEFFREYSale at price 85.25 per share.D2021-11-03Director1k
MOORE DANIEL JEFFREYSale at price 80.00 per share.D2021-10-01Director1k
SKEFFINGTON KEYNA PIDCOCKD2021-09-15General Counsel301
HEBBELINCK TRUID2021-09-15Officer440
MOORE DANIEL JEFFREYSale at price 82.40 per share.D2021-09-01Director1k
MOORE DANIEL JEFFREYSale at price 86.39 per share.D2021-08-02Director1k
ROSENTHAL ARTHUR LEED2021-06-29Director2.34k
NOVAK ALFRED JD2021-06-29Director2.34k
MORRISON HUGH MD2021-06-29Director2.34k
KOZY WILLIAM AD2021-06-29Director2.34k
ENXING SENG STACYD2021-06-29Director2.34k
MOORE DANIEL JEFFREYSale at price 84.20 per share.D2021-06-29Director1k
MOORE DANIEL JEFFREYD2021-06-29Director3.93k
SAIA ANDREA LYNND2021-06-29Director2.34k
BIANCHI FRANCESCOD2021-06-29Director2.34k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to LivaNova PLC. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on LivaNova PLC

Here is the result of two systematic investment strategies applied to LivaNova PLC. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on LivaNova PLC

The following chart shows the equity curve of the two systematic investment strategies applied to LivaNova PLC:

LivaNova PLC automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 33.83% on the backtest period.

Performance at glance

Performance

33.83 %

Latent gain

606.91 $

Invested capital

1793.93 $

Annualized return

8.25 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on LivaNova PLC

This is the result of two momentum investment strategies applied to LivaNova PLC. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on LivaNova PLC

The following chart shows all the entries opened by the momentum investment system on LivaNova PLC:

LivaNova PLC momentum entries
  • The first momentum investment strategy would give 27.15% of return on LivaNova PLC. That represents 1695.62$ of latent gain with 6245.62$ of employed capital.
  • The second momentum investment strategy would give 33.74% of return on LivaNova PLC. That represents 1327.93$ of latent gain with 3935.45$ of employed capital.
Performance at glance (1Q Momentum)

Performance

27.15 %

Latent gain

1695.62 $

Invested capital

6245.62 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

33.74 %

Latent gain

1327.93 $

Invested capital

3935.45 $

Annualized return

9.32 %

Momentum equity curve on LivaNova PLC

The following chart shows the equity curve of the two momentum strategies applied to LivaNova PLC:

LivaNova PLC momentum equity

Note: the dividends potentially given by LivaNova PLC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on LivaNova PLC

The following chart shows the employed capital evolution of the two momentum strategies on LivaNova PLC since the beginning:

LivaNova PLC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on LivaNova PLC

Buy the dip entry openings on LivaNova PLC

LivaNova PLC

The performance achieved by the robo-advisor on LivaNova PLC is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows LivaNova PLC stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of LivaNova PLC, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to LivaNova PLC

The following chart shows the result of the investment strategy applied to LivaNova PLC:

LivaNova PLC

Note: the dividends potentially given by LivaNova PLC are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on LivaNova PLC

The following chart shows the employed capital evolution since the beginning of the investment strategy on LivaNova PLC:

LivaNova PLC

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on LivaNova PLC

In this section, I will compare the three previous investment strategies applied to LivaNova PLC.

Equity curve comparison on LivaNova PLC

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

LivaNova PLC investment strategy comparison

Employed capital comparison on LivaNova PLC

LivaNova PLC investment comparison

Performance comparison on LivaNova PLC

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 33.83% 606.91$ 1793.93$ 8.25%
Momentum 1 quarter 27.15% 1695.62$ 6245.62$ 7.03%
Momentum 2 quarters 33.74% 1327.93$ 3935.45$ 9.32%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

8.25 %

Momentum 1Q

9.32 %

Momentum 2Q

9.32 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with LivaNova PLC:

Positive correlations

Most correlated stocks this year

  • LivaNova PLC

  • Most correlated stocks last 3 months

  • LivaNova PLC

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • XINMING CHINA

  • Note: The algorithm computes the probability of correlation between LivaNova PLC and the other stocks. There may be false positives or some missing correlated stocks. If the price of LivaNova PLC does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name LivaNova PLC
    Country United Kingdom
    City London
    Address 20 Eastbourne Terrace
    Phone 44 20 3325 0660
    Website www.livanova.com
    FullTime employees 3000
    Industry Medical Devices
    Sector Healthcare
    Exchange XNAS
    Ticker LIVN
    Market www.nasdaq.com

    LivaNova PLC ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown